Moxetumomab Pasudotox-tdfk and Pralatrexate Intravenous
Determining the interaction of Moxetumomab Pasudotox-tdfk and Pralatrexate Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: pralatrexate
Brand name: Folotyn
Synonyms: Pralatrexate (Intravenous), PRALAtrexate, Pralatrexate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Pralidoxime
- Moxetumomab Pasudotox-tdfk-Pralidoxime Chloride
- Moxetumomab Pasudotox-tdfk-Pralidoxime Injection
- Moxetumomab Pasudotox-tdfk-Pramasone
- Moxetumomab Pasudotox-tdfk-PramCort
- Moxetumomab Pasudotox-tdfk-Pramcort Cream
- Pralatrexate Intravenous-Moxetumomab pasudotox-tdfk Intravenous
- Pralatrexate Intravenous-Moxifloxacin
- Pralatrexate Intravenous-Moxifloxacin (Systemic)
- Pralatrexate Intravenous-Moxifloxacin Hydrochloride
- Pralatrexate Intravenous-Moxifloxacin Injection
- Pralatrexate Intravenous-Moxifloxacin Intravenous